PBYI
Puma Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$382.08M
P/E Ratio
12.31
EPS
$0.61
Beta
1.18
52W High
$7.68
52W Low
$2.69
50-Day MA
$6.52
200-Day MA
$5.26
Dividend Yield
—
Profit Margin
13.60%
Forward P/E
3.46
PEG Ratio
0.03
About Puma Biotechnology Inc
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | $228.37M |
| Gross Profit (TTM) | $170.21M |
| EBITDA | $47.44M |
| Operating Margin | 22.70% |
| Return on Equity | 28.00% |
| Return on Assets | 10.80% |
| Revenue/Share (TTM) | $4.57 |
| Book Value | $2.59 |
| Price-to-Book | 2.70 |
| Price-to-Sales (TTM) | 1.67 |
| EV/Revenue | 1.237 |
| EV/EBITDA | 5.30 |
| Quarterly Earnings Growth (YoY) | -34.40% |
| Quarterly Revenue Growth (YoY) | 27.70% |
| Shares Outstanding | $50.88M |
| Float | $39.01M |
| % Insiders | 15.63% |
| % Institutions | 72.63% |
Analyst Ratings
Consensus ($5.00 target)
1
HoldData last updated: 4/9/2026